No comments have been submitted
|October 25, 2012: Dr. Julinda Mehilli and Dr. C. Michael Gibson discuss: ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-E
Dr. Julinda Mehilli and Dr. C. Michael Gibson discuss: ISAR-LEFT MAIN 2: A Prospective,
Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with
Unprotected Left Main Disease.
Within the past 12 months, I or my spouse/partner have had a financial
interest/arrangement or affiliation with the organization(s) listed below.
[ Download video ]